Quarterly ResultMay 18, 2026, 04:42 PM
ENvue Medical Q1 Revenue Down 36%; Net Loss Widens to $3.82M
AI Summary
ENvue Medical reported a significant decline in its first-quarter 2026 financial results, with revenues decreasing by 36% to $653,000 and the company incurring a gross loss of $55,000. The net loss widened to $3.82 million, and the net loss available to common stockholders dramatically increased to $22.62 million due to preferred stock dividends and deemed dividends. The company also reported increased cash usage in operations and raised substantial doubt about its ability to continue as a going concern.
Key Highlights
- Revenues decreased 36.3% to $653,000 in Q1 2026 from $1.025 million in Q1 2025.
- Gross profit turned into a loss of $55,000 in Q1 2026, compared to a $369,000 profit in Q1 2025.
- Net loss widened by 104.2% to $3.82 million in Q1 2026 from $1.87 million in Q1 2025.
- Net loss available to common stockholders surged to $22.62 million in Q1 2026.
- Cash used in operating activities increased 221% to $4.31 million in Q1 2026.
- Company reported an accumulated deficit of $112.14 million as of March 31, 2026.
- Management raised substantial doubt about the company's ability to continue as a going concern.
- Cash and cash equivalents decreased 47.1% to $2.24 million as of March 31, 2026.
Price Impact
More from FEED